{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:53:00Z","timestamp":1788897180978,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1684\/bdc.2014.1947","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:58:43Z","timestamp":1565726323000},"page":"741-747","source":"Crossref","is-referenced-by-count":1,"title":["Surveillance du cancer de l\u2019endom\u00e8tre"],"prefix":"10.1016","volume":"101","author":[{"given":"Tristan","family":"Gauthier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Siegerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Monteil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Jammet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Tubiana-Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Aubard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1684\/bdc.2014.1947_bib0005","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1684\/bdc.2014.1947_bib0010","unstructured":"Grosclaude P, Remontet L, Belot A, et al. Survie des personnes atteintes d\u2019un cancer en France 1989-2007. \u00c9tudes \u00e0 partir des registres des cancers du r\u00e9seau Francim. Saint-Maurice : Institut National du Cancer, 2013."},{"key":"10.1684\/bdc.2014.1947_bib0015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/gyno.1994.1282","article-title":"An evaluation of routine follow-up of patients treated for endometrial carcinoma","volume":"55","author":"Shumsky","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1684\/bdc.2014.1947_bib0035","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0040","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post-operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1684\/bdc.2014.1947_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ygyno.2007.06.002","article-title":"Efficacy of routine follow-up in patients with recurrent uterine cancer","volume":"107","author":"Smith","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/ijgc-00009577-200307000-00009","article-title":"Factors influencing survival in endometrial cancer relapsing patients: a cooperation task force (CTF) study","volume":"13","author":"Sartori","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0060","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0959-8049(01)00066-1","article-title":"Value and cost evaluation of routine follow-up for patients with clinical stage I\/II endometrial cancer","volume":"37","author":"Morice","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0065","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/j.ygyno.2007.07.025","article-title":"Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients","volume":"107","author":"Sartori","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of gynecologic oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1684\/bdc.2014.1947_bib0075","first-page":"879","article-title":"Costs and benefits of routine follow-up after curative treatment for endometrial cancer","volume":"157","author":"Agboola","year":"1997","journal-title":"Cmaj"},{"key":"10.1684\/bdc.2014.1947_bib0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2011.07.014","article-title":"Recurrence patterns and surveillance for patients with early stage endometrial cancer","volume":"123","author":"Salani","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ijgc-00009577-200409000-00029","article-title":"The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients","volume":"14","author":"Tjalma","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ygyno.2006.05.013","article-title":"Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/AOG.0b013e31827499a9","article-title":"The utility and management of vaginal cytology after treatment for endometrial cancer","volume":"121","author":"Novetsky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1684\/bdc.2014.1947_bib0100","first-page":"1977","article-title":"An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer","volume":"20","author":"Gadducci","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1684\/bdc.2014.1947_bib0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.AOG.0000194206.38105.c8","article-title":"Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?","volume":"107","author":"Cooper","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1684\/bdc.2014.1947_bib0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/gyno.1995.0012","article-title":"Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme","volume":"59","author":"Reddoch","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0115","first-page":"12","article-title":"Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma","volume":"84","author":"Rose","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1684\/bdc.2014.1947_bib0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1525-1500.1999.99043.x","article-title":"Role of serial tumor markers in the surveillance for recurrence in endometrial cancer","volume":"23","author":"Lo","year":"1999","journal-title":"Cancer Detect Prev"},{"key":"10.1684\/bdc.2014.1947_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9378(90)90400-2","article-title":"Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma","volume":"162","author":"Patsner","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1684\/bdc.2014.1947_bib0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0135","unstructured":"Cancer de l\u2019endom\u00e8tre. Boulogne Billancourt : HAS, INCa, 2010. Coll. \u00ab Recommandations & r\u00e9f\u00e9rentiels \u00bb."},{"key":"10.1684\/bdc.2014.1947_bib0140","first-page":"692","article-title":"Computed tomography in endometrial carcinoma","volume":"95","author":"Connor","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1684\/bdc.2014.1947_bib0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/radiology.204.1.9205223","article-title":"Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging","volume":"204","author":"Kinkel","year":"1997","journal-title":"Radiology"},{"key":"10.1684\/bdc.2014.1947_bib0150","first-page":"266","article-title":"Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET\/CT","volume":"45","author":"Lerman","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1684\/bdc.2014.1947_bib0155","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.ejrad.2012.01.024","article-title":"18F-FDG PET or PET\/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis","volume":"81","author":"Chang","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1684\/bdc.2014.1947_bib0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygyno.2012.10.022","article-title":"Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature","volume":"128","author":"Kadkhodayan","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0165","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3346\/jkms.2010.25.7.1029","article-title":"Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease","volume":"25","author":"Ryu","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1684\/bdc.2014.1947_bib0170","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00259-002-0878-2","article-title":"Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma","volume":"29","author":"Belhocine","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1684\/bdc.2014.1947_bib0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02990022","article-title":"Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer","volume":"17","author":"Saga","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1684\/bdc.2014.1947_bib0180","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1525-1438.2008.01197.x","article-title":"Clinical impact of positron emission tomography or positron emission tomography\/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients","volume":"18","author":"Park","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0185","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00259-006-0251-y","article-title":"Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET\/CT in the detection of recurrence","volume":"34","author":"Sironi","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1684\/bdc.2014.1947_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12149-007-0087-y","article-title":"Performance of FDG-PET\/CT in the diagnosis of recurrent endometrial cancer","volume":"22","author":"Kitajima","year":"2008","journal-title":"Ann Nucl Med"},{"key":"10.1684\/bdc.2014.1947_bib0195","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00259-007-0687-8","article-title":"The clinical impact of [(18)F]FDG PET\/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings","volume":"35","author":"Chung","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1684\/bdc.2014.1947_bib0200","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00259-010-1440-2","article-title":"Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET\/CT studies for the diagnosis of uterine cancer recurrence","volume":"37","author":"Kitajima","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1684\/bdc.2014.1947_bib0205","first-page":"257","article-title":"The value of FDG-PET\/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET\/CT findings with conventional imaging and CA 125 as a tumour marker","volume":"31","author":"Ozcan Kara","year":"2012","journal-title":"Rev Esp Med Nucl"},{"key":"10.1684\/bdc.2014.1947_bib0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/RLU.0b013e31824d24fa","article-title":"Carcinoma endometrium: role of 18-FDG PET\/CT for detection of suspected recurrence","volume":"37","author":"Sharma","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1684\/bdc.2014.1947_bib0215","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/IGC.0b013e3181e2abcc","article-title":"Surveillance procedures for patients treated for endometrial cancer: a review of the literature","volume":"20","author":"Sartori","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/ijgc-00009577-200505000-00001","article-title":"The role of routine follow-up after gynecological malignancy","volume":"15","author":"Kew","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0225","unstructured":"NCCN Guidelines. Endometrial carcinoma. Version 3. Fort Washington (Pennsylvanie, US), NCCN : 2012."},{"key":"10.1684\/bdc.2014.1947_bib0230","series-title":"Follow-up after primary therapy for endometrial cancer: a clinical practice guideline","first-page":"26","article-title":"Gynecologic cancer disease site group","author":"Fung-Kee-Fung","year":"2006"},{"key":"10.1684\/bdc.2014.1947_bib0235","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1470-2045(09)70290-6","article-title":"Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Tangjitgamol","year":"2009","journal-title":"Lancet Oncol"},{"issue":"Suppl 6","key":"10.1684\/bdc.2014.1947_bib0240","doi-asserted-by":"crossref","first-page":"vi35","DOI":"10.1093\/annonc\/mdr374","article-title":"Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Colombo","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3322\/caac.20040","article-title":"Adult cancer survivorship: evolution, research, and planning care","volume":"59","author":"Jacobs","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1684\/bdc.2014.1947_bib0250","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.11372","article-title":"Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma","volume":"97","author":"Hemminki","year":"2003","journal-title":"Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0255","first-page":"303","article-title":"[Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas]","volume":"91","author":"Olschwang","year":"2004","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2014.1947_bib0260","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.gyobfe.2005.09.017","article-title":"[Hereditary predispositions to gynaecological cancers]","volume":"33","author":"Coupier","year":"2005","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1684\/bdc.2014.1947_bib0265","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1684\/bdc.2014.1947_bib0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jgyn.2006.09.005","article-title":"[Lynch syndrome and gynaecologic's cancer: follow-up recommendations]","volume":"36","author":"Magri","year":"2007","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1684\/bdc.2014.1947_bib0275","unstructured":"Recommandations professionnelles. Chirurgie prophylactique des cancers avec pr\u00e9disposition g\u00e9n\u00e9tique - Syndrome HNPCC\/lynch. Boulogne-Billancourt : Institut National du Cancer, 2009."},{"key":"10.1684\/bdc.2014.1947_bib0280","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a gynecologic oncology group study","volume":"24","author":"Barakat","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1947_bib0285","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2011.06.027","article-title":"Patients\u2019 view of routine follow-up after gynecological cancer treatment","volume":"159","author":"Greimel","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1684\/bdc.2014.1947_bib0290","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ygyno.2013.02.018","article-title":"Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based PROFILES registry","volume":"129","author":"Nicolaije","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:21:02Z","timestamp":1602490862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115300618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":58,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0007455115300618"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2014.1947","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}